Effectiveness of Aurix Therapy in Venous Leg Ulcers

Status Recruiting

Clinical Trial Summary

The aim of this trial is to demonstrate the effectiveness of complete wound healing in a prospective, open-label, randomized trial in which venous leg ulcers (VLU)n will be treated using Aurix and compared to patients receiving undefined Usual and Customary Care (UCC)

Clinical Trial Description

Recurrence of ulcers in the leg is common; two-thirds of patients are likely to experience recurring ulcers after the first ulcer. While treatment of the underlying venous disease, depending on the mode of treatment, can lower the recurrence rate in many patients, it does not affect recurrence. Aurix is a platelet-rich plasma (PRP) gel used in the treatment of non-healing chronic wounds. The aim of this trial is to demonstrate the effectiveness, measured as complete wound healing, in a prospective, randomized trial in which venous leg ulcers will be treated using Aurix and standard of care and compared 1:1 to patients receiving undefined Usual and Customary Care (UCC). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02352454
Study type	Interventional
Source	Nuo Therapeutics
Contact	Stacy Gardner
Phone	240-406-1816
Email	sgardner@nuot.com
Status	Recruiting
Phase	N/A
Start date	February 2015
Completion date	July 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00663091` - A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers	Phase 1
Recruiting	`NCT02609594` - Amnioband and Standard of Care vs. Standard of Care Alone in the Treatment of Venous Leg Ulcers	N/A
Unknown status	`NCT02011724` - A Study Of Pain And Quality Of Life Outcomes In Subjects With a Single Painful Venous Leg Ulcer Treated With Apligraf®	Phase 4
Active, not recruiting	`NCT01737762` - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2	Phase 3
Completed	`NCT02222467` - Safety Evaluation of the KLOX BioPhotonic System in Venous Leg Ulcers	N/A
Completed	`NCT01199588` - A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers	Phase 2
Withdrawn	`NCT00953563` - The Mechanism of Action of Unite Biomatrix in Venous Leg Ulcers	N/A
Enrolling by invitation	`NCT02047084` - Comparison of Human Allograft to Apligraf for Venous Leg Ulcers
Completed	`NCT02020746` - Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds	Phase 2
Terminated	`NCT02154087` - A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers	Phase 2
Completed	`NCT02470806` - Single-Use Negative Pressure Wound Therapy System vs. Traditional Negative Pressure Wound Therapy System (tNPWT)	N/A
Suspended	`NCT02577120` - Wound Healing Endpoint and Recurrence	Phase 4
Completed	`NCT01743053` - A Pilot Trial of the Use of ReCell® Autologous Cell Harvesting Device for Venous Leg Ulcers	Phase 4
Recruiting	`NCT02312518` - A Prospective, Randomized Clinical Trial of PRP Concepts Fibrin Bio-Matrix in Chronic Non-Healing Venous Leg Ulcers	N/A
Withdrawn	`NCT02940587` - Effectiveness of Aurix Therapy in Venous Leg Ulcers	Phase 4
Completed	`NCT01036438` - Evaluating the Efficacy of an Absorbent Foam Dressing Containing Silver (Mepilex Ag) Versus the Same Dressing Without Silver Used on Subjects With Venous Leg Ulcers or Mixed Ulcers	Phase 4
Unknown status	`NCT02224300` - Nursing Care With Patients With Venous Leg Ulcers	Phase 2
Completed	`NCT01656889` - Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers	Phase 3
Completed	`NCT02422017` - Topical Timolol Benefit in Venous Ulcers	Phase 2